Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Bladder cancer: new advances in management

The prognosis for bladder cancer can vary significantly based on the stage and grade of the cancer. In the advanced stages, survival rates can be very poor. This article reviews new advances in bladder cancer that could improve patient outcomes.

Bladder cancer is the fifth most common cancer across Europe and in the UK, there are over 10,000 new cases each year.1 It is mostly diagnosed in patients over the age of 55 years with the average age at diagnosis currently 73 years.2 However, treatment options are limited, and survival rates are poor. The five-year survival rate for bladder cancers diagnosed in Europe is around 68% and over 65,000 patients died from it in 2018 alone.1,2 Urothelial carcinoma is the most common type of bladder cancer, accounting for 90% of all cases.3 Yet, between 15% and 18% of bladder cancer


This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
New User Registration
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy
Verified by MonsterInsights